In a 65-year-old patient with sciatica and normal renal function, what medication or intervention should I order, such as ketorolac (Toradol) intramuscular injection?

Ketorolac IM Injection for Sciatica in a 65-Year-Old

For a 65-year-old patient with sciatica and normal renal function, ketorolac (Toradol) IM injection is a reasonable short-term option, but you must limit treatment to a maximum of 5 days and use the lowest effective dose (15-30 mg IM) due to age-related increased risk of gastrointestinal and renal toxicity.

Key Dosing and Safety Parameters

Age 65 is a critical threshold that places your patient in a higher-risk category for NSAID-related adverse events 1, 2. The evidence consistently identifies patients ≥65 years as having elevated risk for:

• Gastrointestinal toxicity (bleeding, perforation, ulceration)
• Renal impairment (even with "normal" baseline function)
• Cardiovascular complications

Specific Ketorolac Recommendations

Dosing for your patient:

• Start with 15-30 mg IM (not the full 60 mg dose used in younger adults) 1
• Maximum duration: 5 days only 1, 3
• Do not exceed 120 mg total daily dose 4

The pharmacokinetics change significantly in elderly patients—elimination half-life increases from 4.5 hours to 7.0 hours, and total plasma clearance decreases 5. This means the drug stays in the system longer and accumulates more readily.

Clinical Decision Algorithm

Before prescribing ketorolac, verify the following:

1. Renal function: Even though you state "no kidney problems," confirm actual creatinine clearance. Age-related decline may not be apparent from serum creatinine alone 6

2. GI risk factors:

   • History of peptic ulcer disease?
   • Significant alcohol use (≥2 drinks/day)?
   • Concurrent aspirin use (even low-dose for cardioprotection)?
   • Concurrent anticoagulants (warfarin, heparin, DOACs)?

   If YES to any: Do not use ketorolac 1, 2

3. Cardiovascular history:

   • Known cardiovascular disease?
   • Hypertension?

   If YES: Use with extreme caution or avoid 1

4. Bleeding risk:

   • Thrombocytopenia?
   • Bleeding disorder?
   • Upcoming surgery?

   If YES: Contraindicated 1

Alternative and Adjunctive Approaches

For neuropathic sciatica pain (which is the predominant component), ketorolac alone is suboptimal. The evidence strongly supports:

First-line neuropathic pain agents:

• Gabapentin: Start 100-300 mg at bedtime, titrate to 900-3600 mg daily in divided doses (slower titration for elderly) 1
• Pregabalin: Start 50 mg three times daily, increase to 100 mg three times daily (requires renal dose adjustment) 1
• Duloxetine: Start 30-60 mg daily 1

If inflammatory/musculoskeletal component predominates:

• Oral NSAIDs may be safer than parenteral ketorolac for short-term use
• Ibuprofen 400-800 mg every 6 hours (max 2400 mg/day) 1
• Consider topical NSAIDs (diclofenac gel) for localized pain with minimal systemic absorption 1

Critical Safety Monitoring

If you proceed with ketorolac:

Monitor baseline and at 3-5 days:

• Blood pressure
• BUN and creatinine
• CBC (for occult bleeding)
• Stool guaiac if any GI symptoms 1

Discontinue immediately if:

• BUN or creatinine doubles
• Blood pressure increases or new hypertension develops
• Any signs of GI bleeding (melena, hematemesis, severe epigastric pain)
• Liver function tests increase >3× upper limit of normal 1

Common Pitfalls to Avoid

1. Duration creep: The 5-day maximum is absolute. Extending beyond this dramatically increases adverse event risk 3, 7

2. Assuming "normal" renal function is protective: Age 65+ itself confers risk even with normal labs 6, 8

3. Ignoring low-dose aspirin: Many elderly patients take 81 mg aspirin for cardioprotection—this combination significantly increases GI bleeding risk 2, 9

4. Treating sciatica as purely inflammatory: Sciatica is predominantly neuropathic pain; NSAIDs provide incomplete relief 10, 8

5. Missing the ceiling effect: Recent evidence suggests ketorolac has a ceiling effect, meaning higher doses don't provide additional analgesia but do increase toxicity 11

Evidence Quality Note

The evidence for ketorolac specifically in sciatica is limited 10. Most data comes from acute low back pain studies 12 or cancer pain guidelines 1. One ED study found ketorolac comparable to acetaminophen-codeine for acute low back pain with fewer adverse effects 12, but this was in younger patients (mean age 34.5 years).

The strongest recommendation: Consider ketorolac as a short-term bridge (≤5 days) while initiating a gabapentinoid or duloxetine for the neuropathic component of sciatica pain, rather than as monotherapy 1, 10, 8.